In breast cancer, pioneering work in risk prediction, modelling genetic susceptibility based on two genes, BRCA1 and BRCA2, [50] has been expanded to the use of polygenic scores, which have improved predictive ability. This evidence concerns the gene BRCA1 and breast cancer.